Medical News

RSS

Innovative nerve graft transplant successful in treatment and prevention of posterior pressure ulcers

The Plastic Surgery Center today announced that an innovative nerve graft transplant performed by Dr. Andrew Elkwood has proven to be successful in treating and preventing posterior pressure ulcers – one of the leading causes of mortality among paraplegics. 49-year old Tory Cavalieri, who underwent the procedure last January, has regained sensation in his posterior and is free of acute pressure sores, which had left him bedridden for years.

9 Feb 2010

IHHS website provides medical resources for people suffering from dermatologic disorder

Therese has suffered with a dermatologic disorder called Hyperhidrosis since she was six years old, leaving her with perpetually wet hands and feet.

9 Feb 2010

Anthem Blue Cross raises premium by 39%: HHS Secretary calls for detailed public justification

U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius today sent a letter to Anthem Blue Cross and called on the company to publicly justify its decision to raise premiums for its California customers by as much as 39 percent. In her letter, Sebelius notes that the parent company of Anthem Blue Cross, WellPoint Incorporated earned $2.7 billion in the last quarter of 2009.

9 Feb 2010

New tool may help standardize use of CT scans in children with minor head injuries

A new tool may help standardize the use of computed tomography (CT scans) in children with minor head injury and help reduce the number of scans, according to a new study in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj091421.pdf.

9 Feb 2010

Thymosin β4 exhibits potential as new therapeutic agent for liver failure due to chronic HBV infection

REGENERX BIOPHARMACEUTICALS, INC. announced today that researchers have correlated Tβ4 levels with the clinical course of patients with hepatitis B virus-related liver failure. It was reported that serum thymosin β4 levels were significantly lower in patients with chronic hepatitis B infection and that the magnitude of the reduction of thymosin β4 was closely related to the severity of the hepatic injury and to patient death. Since patients with higher Tβ4 levels survived the disease, changes in Tβ4 values could reflect outcome in some liver failure patients.

9 Feb 2010

New European-developed system may help dementia patients to lead independent lives

Tens of millions of elderly people in the EU suffering from mild dementia may be able to look after themselves, and free up their carers, thanks to a new European-developed system.

9 Feb 2010

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

Transgenomic, Inc. announced today that it has completed a preliminary study with a leading pharmaceutical company that validates the use of its licensed COLD-PCR technology to detect colorectal tumor-associated KRAS mutations that determine efficacy of recently developed therapies. These were detected in plasma samples in which the mutation levels were too low for detection by standard DNA analysis methodologies such as Sanger sequencing.

9 Feb 2010

P4P reimbursement program does not necessarily translate to patients, says RAND study

Although the idea of pay-for-performance (P4P) is popular among healthcare policy makers and private insurers, the results do not necessarily translate to the patient.

9 Feb 2010

European Urology Forum to be held in Switzerland

The Urology Forum stands out from other meetings because it not only deals with pertinent academic topics but also takes place in a relaxed environment where people can thoroughly examine the information that is presented.

9 Feb 2010

Kofax to provide document capture solution to leading financial services organization

Kofax plc (LSE: KFX), the leading provider of document driven business process automation solutions, today announced it will provide a document capture solution to a leading international financial services organization offering a diverse range of insurance and investment products and services to individuals and corporate customers.

9 Feb 2010

Thrombogenics announces publication of positive microplasmin Phase II trial results

ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces today that the positive microplasmin Phase II trial results, evaluating the product's efficacy and safety in patients who require vitrectomy, have been published in the prestigious American Academy of Ophthalmology's Journal, Ophthalmology, the leading journal for the vitreoretinal community.

9 Feb 2010

Researchers explore cellular networks that regulate cell morphology

Cellular imaging offers a wealth of data about how cells respond to stimuli, but harnessing this technique to study biological systems is a daunting challenge.

9 Feb 2010

HCPRA seeks entries for Hollobon Award

The Health Care Public Relations Association (HCPRA) is pleased to announce this year's Call for Entries for The Hollobon Award.

9 Feb 2010

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Fewer prostate cancers were detected by prostate-specific antigen (PSA) screening in the U.S. than in a European randomized trial because of lower screening sensitivity, according to a new brief communication published online February 8 in the Journal of the National Cancer Institute.

9 Feb 2010

Lundbeck launches web-based initiative to support people with rare diseases

In support of Rare Disease Day 2010, set for February 28, Lundbeck Inc. today launched the Raise Your Hand to Fight Rare Diseases campaign. The web-based initiative is designed to generate support for people with rare diseases and is being conducted in partnership with the National Organization for Rare Disorders (NORD), the sponsor of Rare Disease Day in the United States.

9 Feb 2010

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that it has been awarded a grant of $304,000 from The Michael J. Fox Foundation for Parkinson's Research (MJFF). The grant is to fund a project entitled: “Development of an alpha6*-selective Neuronal Nicotinic Receptor (NNR) Imaging Agent as a Parkinson’s Disease Biomarker” and is the second awarded to Targacept by MJFF in the last six months.

9 Feb 2010

Racial disparities continue in U.S. cancer screening practices

The incidence of advanced breast cancer diagnosis among black women remained 30 percent to 90 percent higher compared to white women between 1992 and 2004, according to new findings by researchers at Fred Hutchinson Cancer Research Center. In addition, the disparity in the incidence of advance colorectal cancer actually widened over this time period as rates fell among whites but increased slightly among blacks.

9 Feb 2010

Italian researchers identify a new therapeutic approach for Ewing sarcoma

Ewing sarcoma (EWS) is a bone tumor of unknown cellular origin that affects children and young adults. The protein CD99 is highly expressed in most cases of EWS, but its function in the disease is unknown.

9 Feb 2010

Synta Pharmaceuticals' STA-9090 inhibits WT1 protein in AML

Synta Pharmaceuticals Corp. today announced that preclinical results presented at the “Bridging the Gap 2010” Hematologic Conference, held in Singapore City, Singapore, February 5-7, 2010, shows that STA-9090, a potent inhibitor of heat shock protein 90 (Hsp90), inhibits the Wilms’ tumor 1 (WT1) protein, a key transcription factor that drives disease progression in acute myeloid leukemia (AML) as well as certain other leukemias. STA-9090 is currently enrolling patients in two clinical trials in AML and other hematologic cancers.

9 Feb 2010

NPSF leads nationwide effort to strengthen partnerships between patients and healthcare providers

The National Patient Safety Foundation (NPSF) will kick off Patient Safety Awareness Week on March 7, 2010, in a concerted effort to raise awareness of patient safety initiatives, improve the quality of health care, and strengthen alliances between patients, families and their healthcare providers.

9 Feb 2010

Medical News

Innovative nerve graft transplant successful in treatment and prevention of posterior pressure ulcers

IHHS website provides medical resources for people suffering from dermatologic disorder

Anthem Blue Cross raises premium by 39%: HHS Secretary calls for detailed public justification

New tool may help standardize use of CT scans in children with minor head injuries

Thymosin β4 exhibits potential as new therapeutic agent for liver failure due to chronic HBV infection

New European-developed system may help dementia patients to lead independent lives

Study validates Transgenomic's COLD-PCR technology for colorectal tumor-associated KRAS mutation detection

P4P reimbursement program does not necessarily translate to patients, says RAND study

European Urology Forum to be held in Switzerland

Kofax to provide document capture solution to leading financial services organization

Thrombogenics announces publication of positive microplasmin Phase II trial results

Researchers explore cellular networks that regulate cell morphology

HCPRA seeks entries for Hollobon Award

U.S. PSA screening efficacy lower than in ERSPC-Rotterdam due to lower testing sensitivity

Lundbeck launches web-based initiative to support people with rare diseases

Targacept receives grant for developing alpha6*-selective NNR Imaging Agent as Parkinson’s disease biomarker

Racial disparities continue in U.S. cancer screening practices

Italian researchers identify a new therapeutic approach for Ewing sarcoma

Synta Pharmaceuticals' STA-9090 inhibits WT1 protein in AML

NPSF leads nationwide effort to strengthen partnerships between patients and healthcare providers

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News